Revlon’s Stahl speaks out
This article was originally published in The Rose Sheet
Executive Summary
Improving business execution and developing consumer- and retail partner-based growth strategies are among top priorities for the company for "foreseeable future," CEO Jack Stahl says May 9, offering analysts insight into his plans to improve the faltering business. Increased "marketing pressure" is being inplemented now as one element. "I think we're going to have a lot to tap into as Revlon re-establishes its core brand positioning and really begins to reclaim its heritage as a power brand," Stahl states. Company will further unveil strategies for growth during an analyst conference tentatively scheduled for Aug. 2, exec adds. Stahl succeeded Jeffrey Nugent as president in February (1"The Rose Sheet" Feb. 25, 2002, p. 6)...
You may also be interested in...
Revlon Brand Management Responsibilities To Be Assigned By New CEO Stahl
One of the first tasks facing Revlon's newly-appointed President and CEO Jack Stahl will be delegating management duties for the company's key Revlon brand following the resignation of Revlon Brand Equity Group Exec VP and General Manger Cheryl Vitali
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.